retatrutide safety trial The Effect of on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity Retatrutide FDA Approval Status: July

23 Provider bias, lack of culturally competent care, and limited access to specialists contribute to these disparities

While this is not a comprehensive review of genetic predispositions for potential psychiatric side effects following GLP-1 signaling, it highlights the importance of future research to better understand individual factors that could contribute to conditions such as depression, anxiety, and suicidal ideation following GLP-1 use

For residents seeking effective, convenient solutions, the integration of telehealth and modern pharmacotherapy, such as the use of GLP-1 medications like Wegovy and Zepbound, offers a path forward

doi: 10.1056/NEJMoa1911303 63 PackerMAnkerSDButlerJFilippatosGPocockSJCarsonPet al

Evidence suggests that T2D can be prevented or delayed, and remission may sometimes be possible (Magliano and Boyko 2021)

How are GLP-1 and GLP-1 + GIP administered